{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:55:09Z","timestamp":1779900909867,"version":"3.53.1"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T00:00:00Z","timestamp":1243382400000},"content-version":"vor","delay-in-days":4195,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Ophthalmologica Scandinavica"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title><jats:p><jats:italic>Purpose:<\/jats:italic> To investigate the therapeutic role of interferon \u03b1 in ocular Beh\u00e7et's disease.<\/jats:p><jats:p><jats:italic>Methods:<\/jats:italic> Three patients with B\u2010 or C\u2010hepatitis and ocular sight\u2010threatening Beh\u00e7et's disease unresponsive to steroids were treated subcutaneously with interferon \u03b1 3 times 10<jats:sup>6<\/jats:sup>\/unit three times per week for a mean period of 22 months (range: 12\u201331 months). The course of ocular and systemic lesions was recorded and compared with a similar pre\u2010treatment period.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic> At least a 50% reduction in the number of ocular relapses was observed in all the patients (mean relapse\/month: 0.41 versus 0.16 in the pre\u2010 and in\u2010treatment period, respectively) while during therapy also each relapse lasted less in all subjects. A reduction of steroid dependence was observed in all patients, while no significant side\u2010effects were related to interferon \u03b1 administration. Two patients who tried to stop interferon \u03b1 therapy showed after a mean period of 12.5 days a recurrence of diffuse uveitis and, one of them experienced oral and genital aphthae as well.<\/jats:p><jats:p><jats:italic>Conclusion:<\/jats:italic> In patients with Beh\u00e7et's disease interferon \u03b1 seems to be a useful alternative therapy for sight\u2010threatening ocular involvement.<\/jats:p>","DOI":"10.1111\/j.1600-0420.1997.tb00638.x","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T00:05:13Z","timestamp":1243469113000},"page":"720-722","source":"Crossref","is-referenced-by-count":36,"title":["Interferon \u03b1 for ocular Beh\u00e7et's disease"],"prefix":"10.1111","volume":"75","author":[{"given":"Paola","family":"Pivetti\u2010Pezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Accorinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Pirraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70226-8"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246374"},{"key":"e_1_2_1_4_1","first-page":"414","article-title":"Ueber rezideivierende, aphthose durch ein virus verursachte geschwure am mund, am auge und an den genitalen","volume":"46","author":"Beh\u00e7et H.","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"e_1_2_1_5_1","first-page":"665","volume-title":"Beh\u00e7et's disease","author":"Dundar S.","year":"1993"},{"key":"e_1_2_1_6_1","first-page":"285","article-title":"Alpha interferon in Beh\u00e7et's disease","volume":"9","author":"Dundar S.","year":"1996","journal-title":"Hematol Rev"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360721"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92549-6"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090030068041"},{"key":"e_1_2_1_10_1","first-page":"1098","article-title":"Systemic interferon \u03b12b in Beh\u00e7et's syndrome","volume":"21","author":"Hamuryudan V.","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_1_11_1","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1970.00990040453009"},{"key":"e_1_2_1_13_1","volume-title":"Uveitis. Fundamentals and clinical practice","author":"Nussenblatt RB","year":"1996"},{"key":"e_1_2_1_14_1","first-page":"20","article-title":"Prognosis in Beh\u00e7et's disease","volume":"17","author":"Pivetti\u2010Pezzi P.","year":"1985","journal-title":"Ann Ophthalmol"},{"key":"e_1_2_1_15_1","volume-title":"\u2018Uveiti\u2019","author":"Pivetti\u2010Pezzi P.","year":"1996"},{"key":"e_1_2_1_16_1","volume-title":"Beh\u00e7et's disease: a contemporary synopsis","author":"Plotkin GR","year":"1988"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100080093034"},{"key":"e_1_2_1_18_1","first-page":"1183","article-title":"Beh\u00e7et's disease induced by interferon therapy for chronic myelogenous leukemia","volume":"22","author":"Segawa F.","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(79)90004-0"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00407749"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72840-5"}],"container-title":["Acta Ophthalmologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0420.1997.tb00638.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0420.1997.tb00638.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:39:13Z","timestamp":1698413953000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0420.1997.tb00638.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1111\/j.1600-0420.1997.tb00638.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0420.1997.tb00638.x","archive":["Portico"],"relation":{},"ISSN":["1395-3907","1600-0420"],"issn-type":[{"value":"1395-3907","type":"print"},{"value":"1600-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}